Effects of rosuvastatin and atorvastatin compared over 52 weeks of treatment in patients with hypercholesterolemia

Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, 1993, Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II), JAMA, 269, 3015, 10.1001/jama.1993.03500230097036 Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, 2001, Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), JAMA, 285, 2486, 10.1001/jama.285.19.2486 Pearson, 2000, The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals, Arch Intern Med, 160, 459, 10.1001/archinte.160.4.459 Olsson, 2001, Effect of rosuvastatin on low-density lipoprotein cholesterol in patients with hypercholesterolemia, Am J Cardiol, 88, 504, 10.1016/S0002-9149(01)01727-1 Nawrocki, 1995, Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor, Arterioscler Thromb Vasc Biol, 15, 678, 10.1161/01.ATV.15.5.678 Jones, 1998, Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES) study, Am J Cardiol, 81, 582, 10.1016/S0002-9149(97)00965-X Remmell, 1980, Assessing dietary adherence in Multiple Risk Factor Intervention Trial (MRFIT), I: use of a dietary monitoring too, JAMA, 76, 351 Friedewald, 1972, Estimation of concentration of low-density lipoprotein cholesterol in plasma, without the use of the preparative ultracentrifuge, Clin Chem, 18, 499, 10.1093/clinchem/18.6.499 Wood, 1998, Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and Other Societies on Coronary Prevention, Eur Heart J, 19, 1434, 10.1053/euhj.1998.1243 Dart, 1997, A multicenter, double-blind, 1-year study comparing safety and efficacy of atorvastatin versus simvastatin in patients with hypercholesterolemia, Am J Cardiol, 80, 39, 10.1016/S0002-9149(97)00280-4 Bertolini, 1997, Efficacy and safety of atorvastatin compared to pravastatin in patients with hypercholesterolemia, Atherosclerosis, 130, 191, 10.1016/S0021-9150(96)06052-2 Davidson, 1997, Comparison of 1-year efficacy and safety of atorvastatin versus lovastatin in primary hypercholesterolemia. Atorvastatin Study Group I, Am J Cardiol, 79, 1475, 10.1016/S0002-9149(97)00174-4 Brown, 1998, Treating patients with documented atherosclerosis to National Cholesterol Education Program-recommended low-density-lipoprotein cholesterol goals with atorvastatin, fluvastatin, lovastatin and simvastatin, J Am Coll Cardiol, 32, 665, 10.1016/S0735-1097(98)00300-3 Hunninghake, 1998, Treating to meet NCEP-recommended LDL cholesterol concentrations with atorvastatin, fluvastatin, lovastatin, or simvastatin in patients with risk factors for coronary heart disease, J Fam Pract, 47, 349 Farnier, 2000, Efficacy of atorvastatin compared with simvastatin in patients with hypercholesterolemia, J Cardiovasc Pharmacol Ther, 5, 27, 10.1177/107424840000500104 Davidson, 2002, Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin vs atorvastatin in patients with type IIA or IIb hypercholesterolemia, Am J Cardiol, 89, 268, 10.1016/S0002-9149(01)02226-3 Downs, 1998, Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS, JAMA, 279, 1616, 10.1001/jama.279.20.1615 Gotto, 2000, Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS), Circulation, 101, 477, 10.1161/01.CIR.101.5.477 Castelli, 1986, A population at risk: prevalence of high cholesterol levels in hypertensive patients in the Framingham Study, Am J Med, 80, 23, 10.1016/0002-9343(86)90157-9 Walldius, 2001, High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study, Lancet, 358, 2026, 10.1016/S0140-6736(01)07098-2